You are here: Home » Current Affairs » Coronavirus » News
Soren seeks 4-week extension from EC to reply to notice over mine lease
icon-arrow-left
Business Standard

CEPI funds Bharat Biotech consortium project for variant-proof Covid-19 jab

CEPI has till date announced funding for nine such projects including the Bharat Biotech one

Topics
Coronavirus | Bharat Biotech | Coronavirus Vaccine

Sohini Das  |  Mumbai 



Bharat Biotech, Covaxin
Photo: Shutterstock

The Coalition for Epidemic Preparedness Innovations (CEPI), a partnership between public, private, philanthropic organisations to develop vaccines against future epidemics, has partnered with Hyderabad based Bharat Biotech, the University of Sydney and ExcellGene of Switzerland to develop a ‘variant-proof’ Covid-19 vaccine.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Tue, May 10 2022. 18:18 IST

RECOMMENDED FOR YOU